1245 related articles for article (PubMed ID: 17607777)
1. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
[TBL] [Abstract][Full Text] [Related]
3. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
5. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
6. What lessons can be learned from animal model studies in viral heart disease?
Gauntt C; Higdon A; Bowers D; Maull E; Wood J; Crawley R
Scand J Infect Dis Suppl; 1993; 88():49-65. PubMed ID: 8390719
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of viral RNA in the murine heart and pancreas with different concentration of coxsackievirus B3.
Kim EO; Joo CH; Ye JS; Jun EJ; Lee HS; Min WK; Lee MS; Lee H; Kim YK
Intervirology; 2006; 49(4):192-9. PubMed ID: 16407656
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route.
Vargová A; Bopegamage S; Borsanyiová M; Petrovicová A; Benkovicová M
Acta Virol; 2003; 47(4):253-7. PubMed ID: 15068381
[TBL] [Abstract][Full Text] [Related]
9. Intracellular viral localization in murine coxsackievirus-B3 myocarditis. Ultrastructural study by electron microscopic in situ hybridization.
Ukimura A; Deguchi H; Kitaura Y; Fujioka S; Hirasawa M; Kawamura K; Hirai K
Am J Pathol; 1997 Jun; 150(6):2061-74. PubMed ID: 9176398
[TBL] [Abstract][Full Text] [Related]
10. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
[TBL] [Abstract][Full Text] [Related]
11. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
13. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
[TBL] [Abstract][Full Text] [Related]
15. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
[TBL] [Abstract][Full Text] [Related]
17. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
18. Colchicine aggravates coxsackievirus B3 infection in mice.
Smilde BJ; Woudstra L; Fong Hing G; Wouters D; Zeerleder S; Murk JL; van Ham M; Heymans S; Juffermans LJ; van Rossum AC; Niessen HW; Krijnen PA; Emmens RW
Int J Cardiol; 2016 Aug; 216():58-65. PubMed ID: 27140338
[TBL] [Abstract][Full Text] [Related]
19. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
[TBL] [Abstract][Full Text] [Related]
20. [Virus demonstration and pathologic changes in different phases of coxsackievirus B myocarditis in mice].
Rabausch-Starz I; Neu N; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():398-403. PubMed ID: 1708625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
